Thursday, January 6, 2022

< + > An Interview With The Team Leader For The Scientific Discovery Of Pfizer’s COVID-19 Drug, Paxlovid

In non-hospitalized high-risk adults with COVID-19, Paxlovid was found to reduce the risk of hospitalization or death by 89% compared to placebo.

at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

< + > AI and Automation in Healthcare – 2026 Health IT Predictions

As we wrap up another year and get ready for 2026 to begin, it is once again time for everyone’s favorite annual tradition of Health IT Pred...